Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pharma: After failed Reppegather deals: Bafin finds accounting errors at Dermapharm

The financial supervisory authority has identified two errors in the 2025 consolidated financial statements. This raises new questions about the pharmaceutical company's dealings with the Reppegather brothers.

Translated from German Read in German

Pharma: After failed Reppegather deals: Bafin finds accounting errors at Dermapharm

We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.

Read the original at handelsblatt.com →

More in Health & Medicine

More from Friday 20 November →